Bariatric Surgery and Decreasing Vascular Risk

Sjöström L Narbro K Sjöström CD . Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–752.

Welbourn R Small P Finlay I . The United Kingdom National Bariatric Surgery Registry. Second Registry Report. London, United Kingdom: National Bariatric Surgery Registry; 2014.

Pournaras DJ Osborne A Hawkins SC . Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252:966–971.

Pournaras DJ le Roux CW . Preventing type 2 diabetes, CVD, and mortality: surgical versus non-surgical weight loss strategies. Curr Atheroscler Rep. 2013;15:367.

Dixon JB O’Brien PE Playfair J . Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomize controlled trial. JAMA. 2008;299:316–323.

Schauer PR Kashyap SR Wolski K . Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–1576.

Mingrone G Panunzi S De Gaetano A . Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–1585.

Ikramuddin S Korner J Lee WJ . Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309:2240–2249.

Wentworth JM Playfair J Laurie C . Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2:545–552.

Sjöström L Peltonen M Jacobson P . Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–2304.

Sjöström L Peltonen M Jacobson P . Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.

Adams TD Davidson LE Litwin SE . Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308:1122–1131.

Miras AD Chuah LL Khalil N . Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study. Diabetologia. 2015;58:1443–1447.

Pournaras DJ Aasheim ET Søvik TT . Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012;99:100–103.

Mingrone G Panunzi S De Gaetano A . Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–973.

Pournaras DJ le Roux CW . Type 2 diabetes: multimodal treatment of a complex disease. Lancet. 2015;386:936–937.

Ricci MA De Vuono S Scavizzi M Gentili A Lupattelli G . Facing morbid obesity: how to approach it [Published online July 17, 2015]. Angiology. doi:10.1177/0003319715595735.